73 related articles for article (PubMed ID: 15739405)
1. [Determination of degradation level of antifungal agent in mice serum by high performance liquid chromatography].
Tang Q; Feng S; Xu X; Huang J
Se Pu; 1997 Mar; 15(2):144-6. PubMed ID: 15739405
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and anti-Candida albicans properties of L-4-oxalysine-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic-containing peptide analogues].
Feng S; Xu X; Zhang H
Yao Xue Xue Bao; 1998 Jun; 33(6):429-35. PubMed ID: 12016912
[TBL] [Abstract][Full Text] [Related]
3. The influence of serum proteins on biological activity of anticandidal peptides containing N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid.
Kasprzak L; Milewski S; Gumieniak J; Borowski E
J Chemother; 1992 Apr; 4(2):88-94. PubMed ID: 1629751
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of thionated analogues of Nva-FMDP and Lys-Nva-FMDP.
Nowak-Jary J; Andruszkiewicz R
Pol J Microbiol; 2009; 58(4):295-9. PubMed ID: 20380139
[TBL] [Abstract][Full Text] [Related]
5. Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase.
Milewski S; Chmara H; Andruszkiewicz R; Borowski E; Zaremba M; Borowski J
Drugs Exp Clin Res; 1988; 14(7):461-5. PubMed ID: 3149235
[TBL] [Abstract][Full Text] [Related]
6. Anticandidal properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides.
Andruszkiewicz R; Milewski S; Zieniawa T; Borowski E
J Med Chem; 1990 Jan; 33(1):132-5. PubMed ID: 2104933
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP.
Milewski S; Mignini F; Covelli I; Borowski E
J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618
[TBL] [Abstract][Full Text] [Related]
8. The influence of L-norvalyl-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic acid, an antifungal agent, on mammalian cells in tissue culture.
Bontemps-Gracz M; Milewski S; Borowski E
Acta Biochim Pol; 1991; 38(2):229-39. PubMed ID: 1814130
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid dipeptides, a novel group of antimicrobial agents.
Andruszkiewicz R; Chmara H; Milewski S; Borowski E
J Med Chem; 1987 Oct; 30(10):1715-9. PubMed ID: 3309312
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole resistant
Shahi G; Kumar M; Skwarecki AS; Edmondson M; Banerjee A; Usher J; Gow NAR; Milewski S; Prasad R
Cell Surf; 2022 Dec; 8():100076. PubMed ID: 35252632
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase.
Milewski S; Andruszkiewicz R; Kasprzak L; Mazerski J; Mignini F; Borowski E
Antimicrob Agents Chemother; 1991 Jan; 35(1):36-43. PubMed ID: 1901701
[TBL] [Abstract][Full Text] [Related]
12. Antihistoplasmal in vitro and in vivo effect of Lys-Nva-FMDP.
Milewski S; Mignini F; Micossi L; Borowski E
Med Mycol; 1998 Jun; 36(3):177-80. PubMed ID: 9776831
[TBL] [Abstract][Full Text] [Related]
13. Amide and ester derivatives of N3-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic acid: the selective inhibitor of glucosamine-6-phosphate synthase.
Zgódka D; Jedrzejczak R; Milewski S; Borowski E
Bioorg Med Chem; 2001 Apr; 9(4):931-8. PubMed ID: 11354676
[TBL] [Abstract][Full Text] [Related]
14. A diffusible analogue of N(3)-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid with antifungal activity.
Zgódka D; Milewski S; Borowski E
Microbiology (Reading); 2001 Jul; 147(Pt 7):1955-1959. PubMed ID: 11429472
[TBL] [Abstract][Full Text] [Related]
15. Peptide dendrimers as antifungal agents and carriers for potential antifungal agent-N
Stolarska M; Gucwa K; Urbańczyk-Lipkowska Z; Andruszkiewicz R
J Pept Sci; 2020 Jan; 26(1):e3226. PubMed ID: 31845463
[TBL] [Abstract][Full Text] [Related]
16. Emerging Anticancer Activity of Candidal Glucoseamine-6-Phosphate Synthase Inhibitors upon Nanoparticle-Mediated Delivery.
Kertmen A; Przysiecka Ł; Coy E; Popenda Ł; Andruszkiewicz R; Jurga S; Milewski S
Langmuir; 2019 Apr; 35(15):5281-5293. PubMed ID: 30912436
[TBL] [Abstract][Full Text] [Related]
17. Facilitated diffusion of glucosamine-6-phosphate synthase inhibitors enhances their antifungal activity.
Janiak A; Cybulska B; Szlinder-Richert J; Borowski E; Milewski S
Acta Biochim Pol; 2002; 49(1):77-86. PubMed ID: 12136959
[TBL] [Abstract][Full Text] [Related]
18. The synthesis and biological activity of lipophilic derivatives of bicine conjugated with N³-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP)-an inhibitor of glucosamine-6-phosphate synthase.
Koszel D; Lącka I; Kozłowska-Tylingo K; Andruszkiewicz R
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):167-73. PubMed ID: 21635214
[TBL] [Abstract][Full Text] [Related]
19. Transport Deficiency Is the Molecular Basis of
Schielmann M; Szweda P; Gucwa K; Kawczyński M; Milewska MJ; Martynow D; Morschhäuser J; Milewski S
Front Microbiol; 2017; 8():2154. PubMed ID: 29163437
[TBL] [Abstract][Full Text] [Related]
20. Fast and reliable determination of the antifungal drug voriconazole in plasma using monolithic silica rod liquid chromatography.
Wenk M; Droll A; Krähenbühl S
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):313-6. PubMed ID: 16488671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
